###begin article-title 0
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
###end article-title 0
###begin title 1
Background:
###end title 1
###begin p 2
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
IRF5 is a transcription factor involved both in the type I interferon and the toll-like receptor signalling pathways. Previously, IRF5 has been found to be associated with systemic lupus erythematosus, rheumatoid arthritis and inflammatory bowel diseases. Here we investigated whether polymorphisms in the IRF5 gene would be associated with yet another disease with features of autoimmunity, multiple sclerosis (MS).
###end p 2
###begin title 3
Methods:
###end title 3
###begin p 4
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
We genotyped nine single nucleotide polymorphisms and one insertion-deletion polymorphism in the IRF5 gene in a collection of 2337 patients with MS and 2813 controls from three populations: two case-control cohorts from Spain and Sweden, and a set of MS trio families from Finland.
###end p 4
###begin title 5
Results:
###end title 5
###begin p 6
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Two single nucleotide polymorphism (SNPs) (rs4728142, rs3807306), and a 5 bp insertion-deletion polymorphism located in the promoter and first intron of the IRF5 gene, showed association signals with values of p<0.001 when the data from all cohorts were combined. The predisposing alleles were present on the same common haplotype in all populations. Using electrophoretic mobility shift assays we observed allele specific differences in protein binding for the SNP rs4728142 and the 5 bp indel, and by a proximity ligation assay we demonstrated increased binding of the transcription factor SP1 to the risk allele of the 5 bp indel.
###end p 6
###begin title 7
Conclusion:
###end title 7
###begin p 8
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
These findings add IRF5 to the short list of genes shown to be associated with MS in more than one population. Our study adds to the evidence that there might be genes or pathways that are common in multiple autoimmune diseases, and that the type I interferon system is likely to be involved in the development of these diseases.
###end p 8
###begin p 9
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
Multiple sclerosis (MS, OMIM 126200) is an inflammatory disease estimated to affect over two million individuals worldwide. MS is not well recognised as an autoimmune disease, but exhibits features of autoimmunity-that is, activation of the immune system in the absence of apparent ongoing infection.1 In MS the presumed target for the autoimmune process is the central nervous system, and the disease manifests itself by immune mediated demyelination and damage to axons. A spectrum of neurological symptoms are found among MS patients, including sensory or motor pareses, visual disturbances, ataxia, pain, cognitive dysfunction and fatigue. MS is a complex disease caused by interaction between environmental and inherited factors. The disease shows familial clustering, and twin studies have revealed that a large portion of this clustering can be attributed to shared genes.2
###end p 9
###begin p 10
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 812 813 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 813 814 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 993 994 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 994 995 986 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 995 996 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1134 1135 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1208 1210 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
A remarkably low number of susceptibility genes for MS have been identified so far. Genome-wide linkage studies have indicated several possible susceptibility loci, but the only locus to be identified across most studies is the major histocompatibility complex (MHC) on chromosome 6p21, were the HLA-DRB1*1501 allele is a well established genetic risk factor for MS.34 This locus does not, however, account for the whole genetic component of MS, and multiple loci with smaller contributions to disease susceptibility are likely to exist. Numerous candidate gene studies have also been performed in MS, but findings from one population have been difficult to replicate in other populations. The protein kinase C alpha (PRKCA) gene is one of few genes reported to be associated with MS in more than one population.56 Recently, the interleukin 7 receptor alpha chain gene (IL7RA) was found to be associated with MS in two independent candidate gene studies and in a genome-wide association study.7-9 The genome-wide association study also identified variants in the interleukin 2 receptor alpha chain gene (IL2RA) as risk factors for MS,7 which is in accordance with findings in a previous candidate gene study.10
###end p 10
###begin p 11
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC2TA</italic>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD24</italic>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 688 694 <span type="species:ncbi:9606">humans</span>
It is relatively common that patients affected by an autoimmune disease suffer from another autoimmune disease, and that members of the same family suffer from different autoimmune diseases. For example, in families with systemic lupus erythematosus (SLE, OMIM 152700), MS and rheumatoid arthritis (RA, OMIM 180300) occur more frequently than in the general population.11 Such observations suggest shared genes or involvement of common cellular pathways in these diseases. This hypothesis is supported by reports on genes found to be associated with more than one autoimmune disease in experimental models of RA and MS.12 Shared genes in autoimmune diseases are becoming apparent also in humans, such as PTPN22 in RA and SLE,13MHC2TA in RA and MS,14 and recently the suggested involvement of CD24 in MS and SLE.15
###end p 11
###begin p 12
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 656 660 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1331 1335 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 1383 1385 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 1439 1443 1439 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1638 1642 1635 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1717 1721 1714 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1931 1935 1928 1932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
###xml 1779 1786 <span type="species:ncbi:9606">patient</span>
The type I interferon (IFN) system has been postulated to play a key role in autoimmune diseases.16 Increased expression of IFN induced genes has been detected in autoimmune diseases like SLE,17 RA,18 Sjogren's syndrome,19 and in a subgroup of MS patients.20 The interferon regulatory factors (IRFs) are major regulators of genes activated by the type I IFNs,21 and a role in the regulation of the immune system is well established for the majority of the members of the IRF family of nine genes. The role of IRF5 in the immune response is not as well established as for other IRFs, but IRF5 has recently received attention in studies on autoimmunity. The IRF5 gene displays a complex transcription pattern with three alternative non-coding 5' exons and at least nine alternatively spliced mRNAs.22IRF5 is expressed in dendritic cells, monocytes and B cells, but its expression can be induced in other cell types by the type I IFNs.23IRF5 regulates the toll-like receptor (TLR) dependent activation of inflammatory cytokines and functions downstream of the TLR-MyD88 pathway where it is activated by MyD88 and TNF receptor associated factor 6 (TRAF6).24 Our original finding of an association between the IRF5 gene and SLE,25 which has been replicated in multiple populations, as well as our recent findings of association between IRF5 and RA26 and inflammatory bowel diseases (IBD),27 provide additional support for the important role of IRF5 and the type I IFN system in autoimmune diseases. Inspired by these findings, and by the role of recombinant IFN beta as a standard treatment of MS, we investigated whether polymorphisms in the IRF5 gene would also be associated with MS. We found that polymorphisms in the IRF5 gene displayed associations with MS in three independent patient cohorts from Spain, Sweden and Finland. The three most strongly associated polymorphisms are located in the promoter region and first intron of IRF5. A functional role is suggested by increased protein binding to the risk alleles of two of these polymorphisms.
###end p 12
###begin title 13
PATIENTS AND METHODS
###end title 13
###begin title 14
Clinical samples
###end title 14
###begin p 15
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 260 268 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
###xml 711 719 <span type="species:ncbi:9606">patients</span>
###xml 1346 1354 <span type="species:ncbi:9606">patients</span>
###xml 1482 1494 <span type="species:ncbi:9606">participants</span>
Cohorts of MS patients collected in Spain, Sweden and Finland were included in the study. All patients had clinically or laboratory supported definite MS according to the Poser criteria28 or fulfilled the criteria of McDonald for MS.29 In total 660 Spanish MS patients were recruited at three public hospitals in the south of Spain: Clinico in Granada (n = 130), Carlos Haya in Malaga (n = 363) and Virgen de la Macarena in Seville (n = 167). The Spanish controls were 833 blood donors without history of inflammatory disease attending the blood banks of Granada (n = 441), Seville (n = 211) and Malaga (n = 181); 67% of the patients and 50% of the controls were female. The Swedish cohort consisted of 1166 MS patients (67% females) and 1235 controls (63% females) of Nordic ethnicity recruited at Danderyd's Hospital or Karolinska University Hospital in Huddinge or in Solna, all located in the Stockholm County of Sweden. Controls were consecutive blood donors of Nordic origin that visited three blood donor facilities in the Stockholm area in 2001 and in 2004/2005. The Finnish cohort consisted of 511 MS trio-families recruited at five centres in Finland: the University Central Hospitals in Helsinki (n = 148 families), Tampere (n = 102), Kuopio (n = 79), Oulu (n = 73), and the Central Hospital of Seinajoki (n = 109); 71% of the Finnish patients were female. The study was approved by the respective local ethics committees and informed consent was obtained from all study participants.
###end p 15
###begin title 16
Genotyping
###end title 16
###begin p 17
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
Nine single nucleotide polymorphisms (SNPs) and one 5 bp bi-alleic insertion-deletion polymorphism (CGGGG indel) in the IRF5 gene were genotyped. The SNPs were genotyped using multiplex fluorescent minisequencing (single base extension) with the SNPstream system (Beckman Coulter).30 The SNP rs4728142 was also genotyped using a homogeneous minisequencing assay with fluorescence polarisation detection (FP-TDI) (Analyst AD, Molecular Probes) in 1440 Swedish samples. The genotype call rate in the samples was on average 96.6% and the genotyping accuracy was 99.8% as estimated from 13.800 genotype comparisons (20% of the genotypes) between repeated assays. The CGGGG indel was amplified as a 100/105 bp polymerase chain reaction (PCR) fragment using fluorescent primers with subsequent fragment analysis on an ABI PRISM 3730 DNA Analyzer (Applied Biosystems, Foster City, California, USA). The GeneMapper v.3.7. software was used for genotype calling. Alternatively, the PCR amplified fragments were separated on 4% MetaPhor high resolution agarose gels (Cambrex Bio Science Rockland Inc, Maine, USA) and visualised using ethidium bromide staining. The call rate for genotyping the CGGGG indel was on average 96.0% in the three cohorts and the genotyping accuracy was 99.1% as estimated from genotype comparison between repeated assays for 15% of the subjects. Samples with a genotype call rate <80% for the 10 markers and four trios with inheritance errors were excluded from the analysis. The PCR and extension primers are provided in the supplementary table S1. All genotyped polymorphisms fulfilled the criteria of Hardy-Weinberg equilibrium in the control samples.
###end p 17
###begin title 18
Electrophoretic mobility shift assay (EMSA)
###end title 18
###begin p 19
For each allele of the polymorphism, pairs of single stranded 5' biotinylated and unlabelled 30-37 bp oligonucleotides (obtained from IDT Inc, Coralville, Iowa, USA) were allowed to anneal to generate double stranded probes (supplementary table S2). Twenty fmoles of labelled probes was incubated for 20 min with 2 mul of nuclear extract prepared from blood cells in a freshly made binding buffer supplemented with poly(dI-dC)ṡpoly(dI-dC) and protease inhibitors. Competition experiments were performed using a 100-fold molar excess of unlabelled probe. The binding reactions were analysed using electrophoresis on 6% polyacrylamide gels and transferred to nylon membranes (Bio-Rad Laboratories, Hercules, California, USA). The biotinylated fragments were detected by a chemiluminescent procedure (LightShift Chemiluminescent EMSA kit, Pierce Biotechnology, Rockford, Illinois, USA).
###end p 19
###begin title 20
Proximity ligation assay (PLA)
###end title 20
###begin p 21
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 822 827 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 828 830 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1514 1519 1497 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1520 1522 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 77 80 <span type="species:ncbi:9685">Cat</span>
###xml 363 369 <span type="species:ncbi:9913">bovine</span>
Polyclonal antibody against SP1 was purchased from Santa Cruz Biotechnology (Cat. no. sc-14027, Santa Cruz, California, USA). The antibody was biotinylated using D-biotin-N-hydroxysuccinimide (Nordic Biosite, Taby, Sweden) according to the recommendation by the manufacturer. The biotinylated antibody was diluted in phosphate buffered saline (PBS) containing 1% bovine serum albumin (BSA) to a final concentration of 100 nM. The anti-SP1 antibody was then combined in a 1:1 ratio with a streptavidin-oligonucleotide conjugate (SoluLink, San Diego, California, USA) in a volume of 20 mul, incubated at room temperature for 1 h, and then stored at 4degreesC until use. High pressure liquid chromatography (HPLC) purified DNA probes (Biomers.net, Ulm, Germany) were made partially double stranded according to Gustafsdottir et al.31 The partially double stranded DNA probes (25 pM) were incubated with 200 ng of Jurkat nuclear extract (Active Motif, Carlsbad, California, USA) in PBS containing 1% BSA, 16 mug/ml of sheared polyA bulk nucleic acid (Sigma-Aldrich, Stockholm, Sweden), 1 mM D-biotin (Molecular Probes, Eugene, Oregon, USA) in a total volume of 9 mul for 30 min at room temperature; 6 mul of 25pM anti-SP1-DNA conjugate was added to the mixture, and the incubation was continued for 2 h at 20degreesC. After the incubations, 35 mul of a combined mixture for ligation and real-time PCR amplification/detection was added. Ligation and PCR amplification/detection was performed according to Gustafsdottir et al.31 Sequences of the primers, probes and the streptavidin-oligonucleotides used in PLA are provided in supplementary table S2.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 5 6 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 611 613 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 933 934 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1102 1104 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1202 1204 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
A chi2 test (p>0.05) was used to assess that the genotype distributions of the polymorphisms fulfilled the criteria of Hardy-Weinberg equilibrium. The PLINK software () was used to compare the allele counts in cases and controls by Fisher's exact test and to calculate odds ratios (OR) with 95% confidence intervals. PLINK was also used to perform the sliding window haplotype association analysis. The Haploview v.3.3. software was used to determine linkage disequilibrium (LD) between the polymorphisms. In the family cohort, the genotype data were analysed using the TRANSMIT 2.5.2. computer program package.32 Alleles that were included in the analysis were required to be transmitted from a least 20 informative meioses, corresponding to the Var (O-E) value of 5 or more in the TRANSMIT analysis. A combined p value from case-control cohorts and trios were calculated using the analytical expression by Jost, k(1-(ln(k))+(-ln(k)2)/2), where k is the product of the p values from the different cohorts (). This formula is an analytical solution of Fischer's original formula for combining p values.33 The ssSNPer tool was used to determine the pair-wise correlation between SNPs in the HapMap data.34
###end p 23
###begin title 24
RESULTS
###end title 24
###begin p 25
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 326 331 326 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f01">fig 1</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 515 516 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 75 82 <span type="species:ncbi:9606">patient</span>
Ten polymorphisms in the IRF5 gene on chromosome 7q32 were genotyped in MS patient samples collected in three European countries. The selected polymorphisms include five SNPs and one insertion-deletion polymorphism (indel) in the promoter region or first intron of IRF5, two SNPs in the 3'UTR and two SNPs downstream of IRF5 (fig 1). The polymorphisms were selected because they have previously been shown to be associated with SLE,253536 RA26 and IBD,27 or have been suggested to modulate the expression of IRF5.35-38
###end p 25
###begin title 26
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 786 790 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 850 854 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 878 880 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 880 882 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 962 966 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 997 1001 985 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1030 1032 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1178 1182 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1272 1276 1260 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1409 1411 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
Schematic illustration of the IRF5 gene with the positions of the analysed polymorphisms. The exons and the 3'-UTR are shown as boxes with the exons labelled 1-9 and the untranslated alternative exons in the 5'-end of IRF5 labelled as 1a, 1b and 1c. The translation initiation site is indicated by an arrow above the gene. The single nucleotide polymorphism (SNP) rs2004640 is located at the splice junction of alternative exon 1b, where it alters a consensus splice donor site that allows expression of IRF5 mRNA containing exon 1b.38 The SNP rs10954213 located in the 3'untranslated region (UTR) of the gene correlates with an altered length of the IRF5 3'UTR and thereby affects the stability of the IRF5 transcript.35 The SNPs rs2280714, located approximately6 kb downstream of the IRF5 gene, has been reported to be correlated with variation in IRF5 mRNA expression levels.3537 A 5 bp insertion-deletion polymorphism (CGGGG indel) in the promoter region of IRF5, identified by sequencing the IRF5 gene in Swedish individuals,35 was included in our study because it is predicted to alter a binding site for the transcription factor SP1, which could affect the expression of IRF5. The SNP rs 12539741 was included because this SNP, and several other SNPs located 3' of IRF5 that are in almost full linkage disequilibrium (LD) with it, show very strong association signals with systemic lupus erythematosus.35
###end title 26
###begin p 27
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t01">table 1</xref>
###xml 610 617 610 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t01">table 1</xref>
###xml 899 906 899 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t02">table 2</xref>
###xml 1014 1014 1014 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t01"/>
###xml 1014 1028 1014 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t02">tables 1 and 2</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
The polymorphisms were first genotyped in a Spanish cohort of MS patients (n = 660) and controls (n = 833). Seven of the 10 polymorphisms showed nominally significant signals of association with MS (p<0.05) (table 1). To replicate this finding, we genotyped the same set of polymorphisms in an independent case-control cohort with 1166 MS patients and 1235 matched controls from Sweden. Two of the SNPs, rs4728142 and rs3807306, and the CGGGG indel polymorphism, showed a nominally significant association (p<0.05) with MS. Each of these three polymorphisms was also associated with MS in the Spanish samples (table 1). In a further attempt to verify these findings from two case-control cohorts of MS patients, we genotyped the same set of polymorphisms in 511 Finnish MS trio families. Using a transmission disequilibrium test, four polymorphisms showed nominally significant association with MS (table 2). Two SNPs, rs4728142 and rs3807306, were nominally significantly associated with MS in all three cohorts (tables 1 and 2).
###end p 27
###begin title 28
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Association analysis of IRF5 polymorphisms with multiple sclerosis in Spanish and Swedish case-control cohorts
###end title 28
###begin p 29
*Major and minor alleles in unaffected subjects.
###end p 29
###begin p 30
p Values below 0.05 are indicated in bold.
###end p 30
###begin title 31
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Association analysis of IRF5 polymorphisms with multiple sclerosis in the Finnish trios
###end title 31
###begin p 32
*Difference between observed and expected transmissions of the associated allele; + denotes increased transmission to affected offspring; p values below 0.05 are indicated in bold.
###end p 32
###begin p 33
###xml 649 653 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 708 712 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 772 776 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 791 798 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t03">table 3</xref>
###xml 800 805 788 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f01">fig 1</xref>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
Information on HLA-DRB1*15 genotype was available from the Swedish cases and controls, and from the Finnish patients (supplementary table S3). In the Swedish dataset most of the association signal was observed in the DR15-negative stratum, whereas in the Finnish dataset the DR2 stratum provided most of the association signal (supplementary table S4). When combining the p values from all cohorts, seven of the 10 polymorphisms exhibited association with MS with p values ranging from 0.0002 to 0.04. The strongest association signals in this combined analysis were observed for the SNP rs4728142 (p = 0.0002) located approximately5 kb upstream of IRF5, the CGGGG indel located 64 bp upstream of exon 1a of IRF5 (p = 0.0005), and the SNP rs3807306 in the first intron of IRF5 (p = 0.0002) (table 3, fig 1).
###end p 33
###begin title 34
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Combined association analysis of IRF5 polymorphisms with multiple sclerosis in three cohorts
###end title 34
###begin p 35
*c/c denotes case-control; p values below 0.05 are indicated in bold.
###end p 35
###begin p 36
###xml 104 112 104 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f02">figure 2</xref>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 815 822 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t04">table 4</xref>
The linkage disequilibrium (LD) pattern of the polymorphisms was similar between the three populations (figure 2), and displayed relatively high LD with pair-wise r2 values of 0.61-0.88 for the three associated polymorphisms in the Spanish, Swedish and Finnish unaffected subjects. We performed haplotype association tests in the three populations to investigate whether haplotypes could capture the association signal at a higher significance than the individual polymorphisms, and whether all three populations harbour the same disease associated haplotype(s). The haplotype analysis was performed using a five marker sliding window approach. The associated risk alleles of the polymorphisms were all present on the most common haplotype, which had a frequency of 0.43-0.51 and was the same in all three cohorts (table 4). The association signals were comparable to those in the analysis of individual polymorphisms.
###end p 36
###begin title 37
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Linkage disequilibrium (LD) structure of the IRF5 gene. Pairwise r2 values are shown for controls or founders in the Spanish, Swedish and Finnish cohorts, respectively. The three most strongly associated markers rs4728142, the CGGGG indel and rs3807306 are in relatively high LD with each other with pair-wise r2 values >0.6.
###end title 37
###begin title 38
Sliding window haplotype association analysis:
###end title 38
###begin p 39
*Haplotype frequency in Finnish trios. daggerDifference between observed and expected transmissions of the associated allele; + denotes increased and - denotes decreased transmission to affected offspring. double dagger39 haplotypes were tested and a conservative Bonferroni correction factor of 39 was applied. The three highest frequency haplotypes in each window are shown. p Values are indicated in bold.
###end p 39
###begin p 40
###xml 454 459 454 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f03">fig 3</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 966 971 966 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f04">fig 4</xref>
We used electrophoretic mobility shift assays (EMSA) to test for differential protein binding to the alleles of the three polymorphisms rs4728142, rs3807306 and the CGGGG indel, which displayed association signals with values of p<0.001 in the combined analysis of the three MS cohorts. This analysis revealed a stronger binding of protein to the risk alleles of the SNP rs4728142 (the A allele) and of the CGGGG indel polymorphism (the 4xCGGGG allele) (fig 3). For the CGGGG indel polymorphisms the insertion of one CGGGG repeat in the longer (4xCGGGG) allele is predicted to create an additional and third binding site for the transcription factor SP1, while the shorter (3xCGGGG) allele has two SP1 binding sites (TFSEARCH: ).39 By using the proximity ligation assay3140 we confirmed that SP1 protein binds to the alleles of the CGGGG indel, and that an increased amount of SP1 is bound to the 4xCGGGG allele than to the 3xCGGGG allele of the indel polymorphism (fig 4).
###end p 40
###begin title 41
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
Electrophoretic mobility shift assay images for the three most strongly associated variants of IRF5. Reactions loaded in lanes 1-4 (from left to right) for each allele contain: (1) labelled probe only; (2) labelled probe and nuclear extract; (3) labelled probe, nuclear extract and the unlabeled probe, which is added as a competitor in 100-fold excess; (4) labelled probe, nuclear extract, and a 100-fold excess of unlabelled probe for the other allele of the polymorphism added as a cross-competitor.
###end title 41
###begin title 42
Result from analysis of the SP1 protein-promoter interaction using the proximity ligation assay. The probes included in the assay shown from left to right are: SP1 mut-negative control probe where four nucleotides within the SP1 consensus binding site have been altered; CGGGG indel 3x and 4x-probes with three or four copies of CGGGG; SP1-positive control probe with SP1 consensus binding site; No lysate-control reaction where no nuclear lysate was added to the reaction. The samples were analysed in duplicate and the result presented are mean values of signal/noise, where the signal from the proximity probe pairs in the sample is divided by the signal in the control reaction without cell lysate. The data shown are from a representative experiment repeated three times with similar results. In each individual experiment the signal obtained by the 4x CGGGG indel probe was 2.6+/-0.3 fold higher than the signal from the 3x CGGGG indel probe.
###end title 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 444 448 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 547 552 535 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0362-f01">fig 1</xref>
###xml 586 590 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 675 676 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1104 1105 1092 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1450 1454 1438 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 102 109 <span type="species:ncbi:9606">patient</span>
Here we describe the association of three polymorphisms in the IRF5 gene with MS in three independent patient cohorts from Spain, Sweden and Finland. The SNPs rs4728142 and rs3807306 reached nominal significance for association in all cohorts and revealed strong signals of association with MS (p = 0.0002) when the data from all three cohorts was combined. The SNP rs4728142 is located approximately5 kb upstream of the alternative exon 1a of IRF5, and rs3807306 is located in the first intron of the gene, 96 bp upstream of alternative exon 1c (fig 1). The SNP rs3807306 was the only IRF5 polymorphism reported in the recently performed genome-wide association study on MS.7 In that study the SNP rs3807306 exhibited association with MS with a TDT p value of 0.014 (), but it did not pass the threshold for inclusion in the confirmatory phase of the study. This study also identified the T allele as the risk allele. It is notable that the initial TDT screening phase of this genome-wide study only had about 6% power to detect each locus at the chosen cut off and with the observed modest risk ratios.7 The effect of this low power becomes apparent when looking at the SNPs in IL2RA and IL7RA, which did not pass the initial p value cut off for the TDT, but turned out to be the most strongly associated markers after the replication phase. In our study the CGGGG indel polymorphisms, located 64 nucleotides upstream of the alternative exon 1a of IRF5, also showed evidence of association with MS. Although the CGGGG indel did not reach statistical significance independently in all three cohorts, the combined analysis revealed a clear association signal between the CGGGG indel and MS (p = 0.0005), with the longer allele (4xCGGGG) as the risk allele.
###end p 44
###begin p 45
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0362-t04">table 4</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 695 697 695 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-6</sup>
###xml 1138 1142 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1308 1310 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 1520 1524 1520 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
The risk alleles of the SNPs rs4728142 and rs3807306 and of the CGGGG indel are present on the same common haplotype in each of the three populations (table 4). In a recent study on IBD we analysed the same set of polymorphisms as in the current study on MS, and found that the same three polymorphisms were associated with IBDs, with the strongest signal of association for the CGGGG indel.27 We have recently performed an association study of a comprehensive set of polymorphisms in IRF5 that were identified by sequencing the introns and exons of IRF5 in SLE patients.41 This analysis identified a set of correlated polymorphisms in IRF5 that gave strong signals of association with SLE (p<10-6), including the SNPs rs4728142, and rs3807306 and the CGGGG indel. In SLE logistic regression analysis conditional only on the CGGGG indel abolished all the other association signals from this set of correlated SNPs. Because the effect size of the polymorphisms are lower in MS than in SLE we cannot distinguish which one of them would be the most likely causal variant in MS. In an earlier association study on RA we analysed five SNPs in IRF5, including the SNPs rs729302, rs375385, rs 2004640 and 3807306, but not the CGGGG indel, and found the strongest signal of association with RA for the SNP rs3807306.26 Taken together, the association results from the current study on MS and previous studies on IBD, SLE and RA indicate that one or more of these correlated polymorphisms in the promoter and first intron of the IRF5 gene could be a universal risk factor for chronic inflammatory disorders, but further studies are required to dissect if the mechanism is the same in all of these disorders.
###end p 45
###begin p 46
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF1</italic>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF4</italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
Using EMSA, as a preliminary functional test for the three polymorphisms in IRF5 that gave the strongest association signals with MS, we observed stronger protein binding to the risk alleles of the SNP rs4728142 (the A allele) and of the CGGGG indel polymorphisms (the 4xCGGGG allele), whereas both alleles of the SNP rs3807306 appear to bind an equal amount of protein. We confirmed experimentally using an antibody against SP1 in the proximity ligation assay31 that an increased amount of transcription factor SP1 binds to the risk allele (the 4xCGGGG allele) of the CGGGG indel polymorphism. This result is also supported indirectly by a study in which they demonstrated that SP1 binds to a similar sequence motif in the IRF1 and IRF4 genes.4243
###end p 46
###begin p 47
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 268 272 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 319 321 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 444 446 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 446 448 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 537 539 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 638 642 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 655 657 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 882 886 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 965 969 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1057 1058 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1125 1127 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1159 1163 1147 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
It is notable that the SNP rs12539741 located in the 3'-end of the IRF5 gene does not show any association with MS in our study. In SLE this SNP and two other linked SNPs, the SNPs rs2070197 in the 3'-UTR of IRF5 and rs10488631 located approximately5 kb downstream of IRF5, give particularly strong association signals.35 Two recent genome-wide association studies failed to detected an association with RA for the SNP rs10488631 or its proxies4445 and in our study on IBD we did not detect an association with the SNP rs10488631 either.27 Thus it appears that in SLE there are two groups of independently associated polymorphisms in the IRF5 gene region,46 whereas in MS, RA and IBD association from only one of these groups is observed. According to data from the HapMap project (), the SNP rs10488631 is in complete LD with multiple SNPs located in a 100 kb region downstream of IRF5, which also contains the transportin 3 (TNPO3) gene. The polymorphisms in the IRF5 gene that we found to be associated with MS in our study are not strongly correlated (r2 0.1-0.2) with the SNP rs10488631 or its proxies in the TNPO3 gene,34 indicating that it actually is IRF5, and not TNPO3, that is primarily responsible for the association with MS that we observe.
###end p 47
###begin p 48
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
Three different European populations were included in the present study, and the observed allele and haplotype frequencies did not show major inter-population differences. The disease predisposing alleles are the same and occur on the same major haplotype in the Spanish, Swedish and Finnish populations. These results indicate that the predisposing alleles are widely distributed in the Caucasian population. The effect sizes of the risk alleles are relatively small, with odds ratios of about 1.2, indicating that large datasets are needed to replicate these findings. The strength of our study is that we used both case-controls and family based association testing. Population stratification artefacts are common in case-control settings, but unlikely in family based studies.47 On the other hand, the TDT may be biased by erroneous detection of association to alleles with high frequency in the analysed populations.48
###end p 48
###begin p 49
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 406 408 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 779 783 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
###xml 1038 1042 1032 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF5</italic>
MS is a common disease, and most likely caused by interaction between multiple common allelic variants of genes. The association of IRF5 polymorphisms with MS in the cohorts studied here suggests that IRF5 is one of these genes that contribute to the disease. Interestingly, in the animal models for MS, experimental autoimmune encephalomyelitis, deletion of the IFN beta gene leads to more severe disease,49 suggesting that the inherent type I IFN function contributes to the autoimmune disease. Currently, the most common therapy in MS is IFN beta, which has been shown to reduce the magnetic resonance imaging activity and relapse rate in MS. This therapeutic effect is consistent with an immunoregulatory role of the type I IFN pathway in MS. The findings from our study add IRF5 to the short list of genes with confirmed association with MS. Our study also contributes to the evidence that there might be genes or pathways that are common between multiple autoimmune diseases, and that the type I IFN signalling system, to which the IRF5 gene belongs, is likely to be one of these pathways.
###end p 49
###begin p 50
The SNPs were genotyped using equipment at the SNP technology platform in Uppsala ().
###end p 50
###begin title 51
REFERENCES
###end title 51
###begin article-title 52
Autoimmune diseases.
###end article-title 52
###begin article-title 53
The genetics of multiple sclerosis. A review.
###end article-title 53
###begin article-title 54
A high-density screen for linkage in multiple sclerosis.
###end article-title 54
###begin article-title 55
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.
###end article-title 55
###begin article-title 56
PRKCA and multiple sclerosis: association in two independent populations.
###end article-title 56
###begin article-title 57
Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population.
###end article-title 57
###begin article-title 58
Risk alleles for multiple sclerosis identified by a genomewide study.
###end article-title 58
###begin article-title 59
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
###end article-title 59
###begin article-title 60
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
###end article-title 60
###begin article-title 61
IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.
###end article-title 61
###begin article-title 62
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus.
###end article-title 62
###begin article-title 63
Genetics of autoimmune neuroinflammation.
###end article-title 63
###begin article-title 64
The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.
###end article-title 64
###begin article-title 65
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
###end article-title 65
###begin article-title 66
A dinucleotide deletion in CD24 confers protection against autoimmune diseases.
###end article-title 66
###begin article-title 67
Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
###end article-title 67
###begin article-title 68
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
###end article-title 68
###begin article-title 69
###xml 155 163 <span type="species:ncbi:9606">patients</span>
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
###end article-title 69
###begin article-title 70
Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism.
###end article-title 70
###begin article-title 71
A subtype of multiple sclerosis defined by an activated immune defense program.
###end article-title 71
###begin article-title 72
IRF family of transcription factors as regulators of host defense.
###end article-title 72
###begin article-title 73
###xml 58 63 <span type="species:ncbi:9606">human</span>
Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function.
###end article-title 73
###begin article-title 74
Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.
###end article-title 74
###begin article-title 75
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
###end article-title 75
###begin article-title 76
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.
###end article-title 76
###begin article-title 77
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.
###end article-title 77
###begin article-title 78
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
###end article-title 78
###begin article-title 79
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
###end article-title 79
###begin article-title 80
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
###end article-title 80
###begin article-title 81
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.
###end article-title 81
###begin article-title 82
In vitro analysis of DNA-protein interactions by proximity ligation.
###end article-title 82
###begin article-title 83
A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission.
###end article-title 83
###begin article-title 84
ssSNPer: identifying statistically similar SNPs to aid interpretation of genetic association studies.
###end article-title 84
###begin article-title 85
###xml 102 107 <span type="species:ncbi:9606">human</span>
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
###end article-title 85
###begin article-title 86
Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation.
###end article-title 86
###begin article-title 87
###xml 24 29 <span type="species:ncbi:9606">human</span>
Mapping determinants of human gene expression by regional and genome-wide association.
###end article-title 87
###begin article-title 88
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
###end article-title 88
###begin article-title 89
Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.
###end article-title 89
###begin article-title 90
Cytokine detection by antibody-based proximity ligation.
###end article-title 90
###begin article-title 91
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5bp length polymorphism as strong risk factor for systemic lupus erythematosus.
###end article-title 91
###begin article-title 92
###xml 52 57 <span type="species:ncbi:9606">human</span>
Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.
###end article-title 92
###begin article-title 93
Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene.
###end article-title 93
###begin article-title 94
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.
###end article-title 94
###begin article-title 95
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 95
###begin article-title 96
Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
###end article-title 96
###begin article-title 97
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).
###end article-title 97
###begin article-title 98
Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test.
###end article-title 98
###begin article-title 99
IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
###end article-title 99
###begin p 100
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests:</bold>
Competing interests: None.
###end p 100
###begin p 101
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: Financial support for the study was provided by the Swedish Research Council and the Knut and Alice Wallenberg Foundation (to A-CS), the Academy of Finland, the Sigrid Juselius Foundation and Helsinki University Central Hospital (to PJT and LP), the Center of Excellence for Disease Genetics of the Academy of Finland (to LP), the Paulo Foundation (to PJT), the Finnish Cultural Foundation (to PJT and AB), the Helsinki Biomedical Graduate School (to AB), the Nils and Bibbi Jensen's Foundation (to JH) and by the grants PN-SAF 2006-02023 (to AA) and FIS-PI041298 (to FM).
###end p 101
###begin p 102
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ethics approval:</bold>
Ethics approval: The study was approved by the respective local ethics committees in Spain, Sweden and Finland.
###end p 102
###begin p 103
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Patient consent:</bold>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Patient consent: Informed consent was obtained from the patients for publication of their details in this report.
###end p 103
###begin p 104
black triangle right Additional tables are published online only at 
###end p 104
###begin p 105
GK and JKS contributed equally to this work
###end p 105

